Top in allergy/asthma: Obesity drugs improve asthma; deep cleaning helps airway

Adults who used a glucagon-like peptide receptor agonist for weight loss and had asthma experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.

“Although designed predominantly for weight loss, it seems that GLP-1s will have widespread benefits on comorbidities relating to obesity, including asthma,” Heath Heatley, PhD, senior researcher at Observational and Pragmatic Research Institute, said during his presentation. “Quantifying these associations will be useful in considering the health economic choices around using these drugs.”

It was the top story in allergy/asthma last week.

In another top story, researchers found that airway resistance improved in patients who received a periodontal deep cleaning, potentially helping to prevent respiratory diseases.

Read these and more top stories in allergy/asthma below:

Patients with asthma, obesity experience improved control with GLP-1 RAs

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress. Read more.

Airway resistance improves after periodontal treatment

The next time you have patients who struggle with airway resistance, you may want to refer them to your local periodontist for a deep cleaning, according to a poster presented at the European Respiratory Society International Congress. Read more.

Q&A: How changing your beliefs can advance your career trajectory

Your mindset and beliefs have a direct impact on your career performance, according to Laura Desveaux, PhD, PT, scientific director and learning health system program lead at Trillium Health Partners’ Institute for Better Health. Read more.

Inflammation, mucus plugging improve by 4 weeks with dupilumab

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress. Read more.

Cockroach, mouse allergens drive upper respiratory infections in children with asthma

Risks for respiratory viral infections increased among children with asthma who were exposed to high levels of floor cockroach and mouse airborne allergens, results from a study published in The Journal of Allergy and Clinical Immunology showed. Read more.